Novartis to spin off eye unit Alcon
Novartis has announced plans to spin off its eye-care unit Alcon into a standalone entity.
Read More
Tag: eye
Europe’s first stem cell therapy backed by NICE
Chiesi’s Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition.
Read More
Novartis, NHS joint working pact delivers new eye service
People living in Ayrshire and Arran who have some of the most common forms of avoidable sight loss will now be able to benefit from a new facility designed specifically for the eye service through a partnership between Novartis Pharmaceuticals UK and the NHS.
Read More
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
